Harpreet S. Dhaliwal - 02 Sep 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Signature
Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
02 Sep 2025
Net transactions value
-$48,539
Form type
4
Filing time
04 Sep 2025, 16:12:12 UTC
Previous filing
25 Apr 2025
Next filing
10 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dhaliwal Harpreet S. Chief Technical Ops Officer C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact 04 Sep 2025 0001886794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $9,184 -291 -0.8% $31.56 36,121 02 Sep 2025 Direct F1, F2
transaction PCVX Common Stock Tax liability $24,711 -783 -2.2% $31.56 35,338 02 Sep 2025 Direct F1
transaction PCVX Common Stock Tax liability $14,644 -464 -1.3% $31.56 34,874 02 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2 Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.